MELD Stratified Outcomes among Recipients with Diabetes or Hypertension

Ashwani K. Singal, Mohsen Hasanin, Mohamed Kaif, Russell W. Wiesner, Yong Fang Kuo

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Background and Aim: Data are scanty on allocating simultaneous liver kidney (SLK) based on model for end-stage disease (MELD) score. Diabetes mellitus (DM) and hypertension (HTN) are frequent in cirrhosis patients. We analyzed transplant recipients with DM and/or HTN to compare MELD-based outcomes of SLK to liver transplantation alone (LTA). Materials and Methods: Of 13,584 first deceased donor liver transplantation among patients with DM and/or HTN (1530 or 11.2% SLK), MELD score predicted SLK [1.02 (1.01-1.03)]. SLK was beneficial for 5-year patient survival at MELD score ≥43 (78.6% vs. 62.6%, P=0.017), but not at MELD score <29 (74.8% vs. 76.2%, P=0.63). Among 11,405 recipients (976 SLK) at MELD score <29, SLK (n=816) was beneficial compared with 706 LTA [75% vs. 64%, P<0.001; 0.71 (0.55-0.91)] at serum creatinine (SC) ≥2 but not at SC<2 [73% vs. 76%, P=0.32; 0.85 (0.60-1.2)]. Among patients with MELD score 29 to 42, SLK (n=484) and LTA (n=1403) had similar survival [69% vs. 69%, P=0.58; 0.9 (0.7-1.5)]. Among patients with MELD score ≥43, SLK (n=70) was associated with 35% improved patient survival at 5 years compared with 222 LTA [0.65 (0.46-0.93)]. Conclusions: Among patients with DM and/or HTN, SLK is useful at: (a) MELD score <29 and SC≥2 and (b) MELD score ≥43. Prospective studies are needed to confirm these findings as basis to optimize use of SLK.

Original languageEnglish (US)
Pages (from-to)67-72
Number of pages6
JournalJournal of Clinical Gastroenterology
Volume52
Issue number1
DOIs
StatePublished - Jan 1 2017
Externally publishedYes

Fingerprint

Hypertension
Kidney
Liver
Liver Transplantation
Diabetes Mellitus
Survival
Creatinine
Serum
Fibrosis
Tissue Donors
Prospective Studies

Keywords

  • MELD
  • SLK
  • transplant
  • UNOS

ASJC Scopus subject areas

  • Gastroenterology

Cite this

MELD Stratified Outcomes among Recipients with Diabetes or Hypertension. / Singal, Ashwani K.; Hasanin, Mohsen; Kaif, Mohamed; Wiesner, Russell W.; Kuo, Yong Fang.

In: Journal of Clinical Gastroenterology, Vol. 52, No. 1, 01.01.2017, p. 67-72.

Research output: Contribution to journalArticle

Singal, Ashwani K. ; Hasanin, Mohsen ; Kaif, Mohamed ; Wiesner, Russell W. ; Kuo, Yong Fang. / MELD Stratified Outcomes among Recipients with Diabetes or Hypertension. In: Journal of Clinical Gastroenterology. 2017 ; Vol. 52, No. 1. pp. 67-72.
@article{bd168e982cda47d883d97678c469d223,
title = "MELD Stratified Outcomes among Recipients with Diabetes or Hypertension",
abstract = "Background and Aim: Data are scanty on allocating simultaneous liver kidney (SLK) based on model for end-stage disease (MELD) score. Diabetes mellitus (DM) and hypertension (HTN) are frequent in cirrhosis patients. We analyzed transplant recipients with DM and/or HTN to compare MELD-based outcomes of SLK to liver transplantation alone (LTA). Materials and Methods: Of 13,584 first deceased donor liver transplantation among patients with DM and/or HTN (1530 or 11.2{\%} SLK), MELD score predicted SLK [1.02 (1.01-1.03)]. SLK was beneficial for 5-year patient survival at MELD score ≥43 (78.6{\%} vs. 62.6{\%}, P=0.017), but not at MELD score <29 (74.8{\%} vs. 76.2{\%}, P=0.63). Among 11,405 recipients (976 SLK) at MELD score <29, SLK (n=816) was beneficial compared with 706 LTA [75{\%} vs. 64{\%}, P<0.001; 0.71 (0.55-0.91)] at serum creatinine (SC) ≥2 but not at SC<2 [73{\%} vs. 76{\%}, P=0.32; 0.85 (0.60-1.2)]. Among patients with MELD score 29 to 42, SLK (n=484) and LTA (n=1403) had similar survival [69{\%} vs. 69{\%}, P=0.58; 0.9 (0.7-1.5)]. Among patients with MELD score ≥43, SLK (n=70) was associated with 35{\%} improved patient survival at 5 years compared with 222 LTA [0.65 (0.46-0.93)]. Conclusions: Among patients with DM and/or HTN, SLK is useful at: (a) MELD score <29 and SC≥2 and (b) MELD score ≥43. Prospective studies are needed to confirm these findings as basis to optimize use of SLK.",
keywords = "MELD, SLK, transplant, UNOS",
author = "Singal, {Ashwani K.} and Mohsen Hasanin and Mohamed Kaif and Wiesner, {Russell W.} and Kuo, {Yong Fang}",
year = "2017",
month = "1",
day = "1",
doi = "10.1097/MCG.0000000000000818",
language = "English (US)",
volume = "52",
pages = "67--72",
journal = "Journal of Clinical Gastroenterology",
issn = "0192-0790",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

TY - JOUR

T1 - MELD Stratified Outcomes among Recipients with Diabetes or Hypertension

AU - Singal, Ashwani K.

AU - Hasanin, Mohsen

AU - Kaif, Mohamed

AU - Wiesner, Russell W.

AU - Kuo, Yong Fang

PY - 2017/1/1

Y1 - 2017/1/1

N2 - Background and Aim: Data are scanty on allocating simultaneous liver kidney (SLK) based on model for end-stage disease (MELD) score. Diabetes mellitus (DM) and hypertension (HTN) are frequent in cirrhosis patients. We analyzed transplant recipients with DM and/or HTN to compare MELD-based outcomes of SLK to liver transplantation alone (LTA). Materials and Methods: Of 13,584 first deceased donor liver transplantation among patients with DM and/or HTN (1530 or 11.2% SLK), MELD score predicted SLK [1.02 (1.01-1.03)]. SLK was beneficial for 5-year patient survival at MELD score ≥43 (78.6% vs. 62.6%, P=0.017), but not at MELD score <29 (74.8% vs. 76.2%, P=0.63). Among 11,405 recipients (976 SLK) at MELD score <29, SLK (n=816) was beneficial compared with 706 LTA [75% vs. 64%, P<0.001; 0.71 (0.55-0.91)] at serum creatinine (SC) ≥2 but not at SC<2 [73% vs. 76%, P=0.32; 0.85 (0.60-1.2)]. Among patients with MELD score 29 to 42, SLK (n=484) and LTA (n=1403) had similar survival [69% vs. 69%, P=0.58; 0.9 (0.7-1.5)]. Among patients with MELD score ≥43, SLK (n=70) was associated with 35% improved patient survival at 5 years compared with 222 LTA [0.65 (0.46-0.93)]. Conclusions: Among patients with DM and/or HTN, SLK is useful at: (a) MELD score <29 and SC≥2 and (b) MELD score ≥43. Prospective studies are needed to confirm these findings as basis to optimize use of SLK.

AB - Background and Aim: Data are scanty on allocating simultaneous liver kidney (SLK) based on model for end-stage disease (MELD) score. Diabetes mellitus (DM) and hypertension (HTN) are frequent in cirrhosis patients. We analyzed transplant recipients with DM and/or HTN to compare MELD-based outcomes of SLK to liver transplantation alone (LTA). Materials and Methods: Of 13,584 first deceased donor liver transplantation among patients with DM and/or HTN (1530 or 11.2% SLK), MELD score predicted SLK [1.02 (1.01-1.03)]. SLK was beneficial for 5-year patient survival at MELD score ≥43 (78.6% vs. 62.6%, P=0.017), but not at MELD score <29 (74.8% vs. 76.2%, P=0.63). Among 11,405 recipients (976 SLK) at MELD score <29, SLK (n=816) was beneficial compared with 706 LTA [75% vs. 64%, P<0.001; 0.71 (0.55-0.91)] at serum creatinine (SC) ≥2 but not at SC<2 [73% vs. 76%, P=0.32; 0.85 (0.60-1.2)]. Among patients with MELD score 29 to 42, SLK (n=484) and LTA (n=1403) had similar survival [69% vs. 69%, P=0.58; 0.9 (0.7-1.5)]. Among patients with MELD score ≥43, SLK (n=70) was associated with 35% improved patient survival at 5 years compared with 222 LTA [0.65 (0.46-0.93)]. Conclusions: Among patients with DM and/or HTN, SLK is useful at: (a) MELD score <29 and SC≥2 and (b) MELD score ≥43. Prospective studies are needed to confirm these findings as basis to optimize use of SLK.

KW - MELD

KW - SLK

KW - transplant

KW - UNOS

UR - http://www.scopus.com/inward/record.url?scp=85038240508&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85038240508&partnerID=8YFLogxK

U2 - 10.1097/MCG.0000000000000818

DO - 10.1097/MCG.0000000000000818

M3 - Article

C2 - 28906426

AN - SCOPUS:85038240508

VL - 52

SP - 67

EP - 72

JO - Journal of Clinical Gastroenterology

JF - Journal of Clinical Gastroenterology

SN - 0192-0790

IS - 1

ER -